Olaparib |
Olaparib : Inhibitor of PARP1 and PARP
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PARP1 |
|
|
| PARP2 |
|
|
Inhibitor
10-300 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - TNKS 1.5 uM, PARP3 230 nM, PARP4 410 nM, TNKS1 1230 nM, PARP10 1250 nM
Potency Assay Off-Target:
In vitro activity assay with biotinylated-NAD. In in vitro ADP ribosylation assays, oliparib was onl ...
Selectivity Assessment Description:
In vitro activity assay with biotinylated-NAD. In in vitro ADP ribosylation assays, olaparib was onl ...
Potency Cellular
In Vitro
PARP1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm8001263
PARP2
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm8001263
In Vivo Validations
Mouse, Rat, Dog
Dose: 10 mg/kg (mouse) , 15 mg/kg (rat), 2.5 mg/kg (dog)
Route of delivery:
Intravenous, Oral
Plasma half life:
53 min (rat, IV), 170 min (dog, IV)
Systemic clearance:
49 mL/min/kg (rat, IV), 5.4 mL/min/kg (dog, IV)
Organ of interest (O):
SW620 xenograft
Target engagement assay:
Not available
DOI Reference: 10.1021/jm8001263
Chemical Information
| Molecular Formula | C24H23FN4O3 |
| SMILEs | O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1 |
| InChI | InChI=1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30) |
| Molecular weight | 434.18 Da |
| AlogP | 0.0 |
| HBond acceptors | 7 |
| HBond donors | 1 |
| Atoms | 55 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.